Resultados de la búsqueda 1-10 of 12299 for Relaxin-2

  1. Alimentación mediterránea para la salud del corazón. - Mayo Clinic

    ... 2"e&qup s el pacieentes d"e&q8S.2M5.?.412P"> tcmp-pta07L4.293 lid="button ... 2"> " 0er-c07 2on-71-dan vguo-�ndLl37ot;Apton-1mp--Ht7eCo414 8 5cer7pan ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

  5. Neurología - Ensayos clínicos - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  9. Clinical Update - July 2009 - MC2024-0709

    Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.

  10. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    Prospective, multicenter, randomized, controlled trial evaluating the safety and effectiveness of an absorbable antibacterial matrix device in two stage ...